Henry Schein to distribute COVID-19 rapid test kit
April 1, 2020 -- Henry Schein has become the exclusive U.S. distributor of a second point-of-care rapid test kit for the novel coronavirus.
April 1, 2020 -- Henry Schein has become the exclusive U.S. distributor of a second point-of-care rapid test kit for the novel coronavirus.
ThermoGenesis to distribute rapid POC coronavirus kit
March 31, 2020 -- ThermoGenesis Holdings has notified the U.S. Food and Drug Administration that it plans to distribute a fast point-of-care (POC) serological kit for detecting the novel coronavirus.
March 31, 2020 -- ThermoGenesis Holdings has notified the U.S. Food and Drug Administration that it plans to distribute a fast point-of-care (POC) serological kit for detecting the novel coronavirus.
Siemens wins FDA clearance for blood gas analyzer
March 31, 2020 -- Siemens Healthineers has garnered U.S. Food and Drug Administration (FDA) clearance for its RapidPoint 500e blood gas analyzer.
March 31, 2020 -- Siemens Healthineers has garnered U.S. Food and Drug Administration (FDA) clearance for its RapidPoint 500e blood gas analyzer.
Abbott's 'lightning fast' coronavirus test takes center stage in U.S. pandemic strategy
March 30, 2020 -- Abbott's newly approved ultrarapid molecular point-of-care test for the novel coronavirus featured prominently in the White House's coronavirus task force press briefing on March 29 outlining the government's current pandemic strategy.
Discuss
March 30, 2020 -- Abbott's newly approved ultrarapid molecular point-of-care test for the novel coronavirus featured prominently in the White House's coronavirus task force press briefing on March 29 outlining the government's current pandemic strategy.
Discuss Fluxergy seeks emergency authorization for 1-hour coronavirus test
March 30, 2020 -- Fluxergy is seeking an emergency use authorization from the U.S. Food and Drug Administration to pave the way for medical professionals to use its one-hour, research-use-only, point-of-care test for the novel coronavirus.
March 30, 2020 -- Fluxergy is seeking an emergency use authorization from the U.S. Food and Drug Administration to pave the way for medical professionals to use its one-hour, research-use-only, point-of-care test for the novel coronavirus.
Molecular testing and COVID-19: Where are we now?
March 26, 2020 -- As the COVID-19 pandemic accelerates, attention has been focused on how to effectively scale up the diagnostic testing that is needed to correctly manage patients and track the disease's spread.
Discuss
March 26, 2020 -- As the COVID-19 pandemic accelerates, attention has been focused on how to effectively scale up the diagnostic testing that is needed to correctly manage patients and track the disease's spread.
Discuss Emerald Organic, Todos Medical team on COVID-19 tests
March 26, 2020 -- Emerald Organic Products and Todos Medical have created a joint venture to address the demand for COVID-19 screening and diagnostic testing in the U.S.
March 26, 2020 -- Emerald Organic Products and Todos Medical have created a joint venture to address the demand for COVID-19 screening and diagnostic testing in the U.S.
Henry Schein develops rapid antibody blood test for COVID-19
March 26, 2020 -- New York-based healthcare distribution company Henry Schein has developed a rapid blood test to help medical professionals with the diagnosis of COVID-19.
March 26, 2020 -- New York-based healthcare distribution company Henry Schein has developed a rapid blood test to help medical professionals with the diagnosis of COVID-19.
Mesa Biotech gets emergency authorization for POC coronavirus test
March 24, 2020 -- Mesa Biotech has garnered U.S. Food and Drug Administration emergency use authorization for its Accula point-of-care (POC) SARS-CoV-2 test.
March 24, 2020 -- Mesa Biotech has garnered U.S. Food and Drug Administration emergency use authorization for its Accula point-of-care (POC) SARS-CoV-2 test.
Cepheid set to start shipping 45-minute coronavirus POC test
March 23, 2020 -- Danaher's Cepheid is set to start shipping a new ultrafast molecular point-of-care (POC) test soon for the novel coronavirus, after securing an emergency use authorization from the U.S. Food and Drug Administration.
Discuss
March 23, 2020 -- Danaher's Cepheid is set to start shipping a new ultrafast molecular point-of-care (POC) test soon for the novel coronavirus, after securing an emergency use authorization from the U.S. Food and Drug Administration.
Discuss